Moritz Meyer-Jens

3PUBLICATIONS
14CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 31, 2026
JAK1/2 inhibitor ruxolitinib reduces aggregates in cardiac proteinopathy.

Erda Alizoti, Leonie Ewald, Simona Parretta

|Sep 09, 2022
ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes.

Antonia T L Zech, Maksymilian Prondzynski, Sonia R Singh

Pageof 1